OTCM
HLYK
Market cap9mUSD
Jul 09, Last price
3.17USD
1D
7.88%
1Q
7.21%
IPO
604.80%
Name
Healthlynked Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
HealthLynked Corporation operates a digital platform in the United States for the management and archiving of patient information, utilizing cloud technology. The company's business activities are organized into four main segments: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division offers specialized medical care, including obstetrics and gynecology, and provides functional medicine services with a focus on neurodegenerative conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. This segment also includes "Bridging the Gap Physical Therapy," a practice dedicated to enhancing patient recovery and managing pain without reliance on medication or surgery. The Digital HealthCare division oversees the HealthLynked Network, an online cloud-based system that enables both patients and doctors to monitor medical records. Patients can also input comprehensive personal health details, covering past surgeries, medications, allergies, and family medical histories. Additionally, this division provides an online functionality for patients to schedule appointments with healthcare providers. The ACO/MSO division manages an Accountable Care Organization and a Management Service Organization. These entities assist physician practices in delivering patient care, particularly through the Medicare Shared Savings Program, and offer professional consulting services to other healthcare providers and ACOs under contractual agreements. The Medical Distribution division functions as an online distributor, supplying discounted medical products directly to individual consumers and medical practices. HealthLynked was founded in 2014 and its corporate headquarters are located in Naples, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||